Xuefei Bao

573 total citations · 1 hit paper
29 papers, 419 citations indexed

About

Xuefei Bao is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Xuefei Bao has authored 29 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 14 papers in Molecular Biology and 3 papers in Biochemistry. Recurrent topics in Xuefei Bao's work include Chemical Synthesis and Reactions (6 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Xuefei Bao is often cited by papers focused on Chemical Synthesis and Reactions (6 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Catalytic Reactions (4 papers). Xuefei Bao collaborates with scholars based in China and United States. Xuefei Bao's co-authors include Guoliang Chen, Wei Xiao, Yong-Sheng Zhang, Xuan Zhao, Ziao Liu, Tao Shi, Jingyu Yang, Lihui Wang, Xiaorui Jiang and Chunfu Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Green Chemistry.

In The Last Decade

Xuefei Bao

26 papers receiving 416 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective

2022 200 citations Yong-Sheng Zhang, Xuefei Bao et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuefei Bao China	8	180	122	79	48	41	29	419
Junjie Yang China	14	188 1.0×	148 1.2×	116 1.5×	59 1.2×	25 0.6×	42	564
Takeshi Nakanishi Japan	11	134 0.7×	88 0.7×	44 0.6×	16 0.3×	12 0.3×	41	486
Frederick Wong United States	11	212 1.2×	179 1.5×	84 1.1×	26 0.5×	15 0.4×	18	456
Tai Wei Ly Taiwan	13	139 0.8×	178 1.5×	42 0.5×	18 0.4×	11 0.3×	26	435
Tomio Kimura Japan	12	164 0.9×	112 0.9×	19 0.2×	28 0.6×	25 0.6×	22	376
Joseph A. Tino United States	13	169 0.9×	172 1.4×	30 0.4×	18 0.4×	22 0.5×	27	469
Timothy B. Durham United States	15	232 1.3×	248 2.0×	15 0.2×	27 0.6×	12 0.3×	21	518
Stephen Eisennagel United States	8	266 1.5×	97 0.8×	27 0.3×	39 0.8×	19 0.5×	12	480
Charles B. Spainhour United States	13	155 0.9×	39 0.3×	41 0.5×	34 0.7×	9 0.2×	23	397

Countries citing papers authored by Xuefei Bao

Since Specialization

Citations

This map shows the geographic impact of Xuefei Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Bao more than expected).

Fields of papers citing papers by Xuefei Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefei Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Bao. The network helps show where Xuefei Bao may publish in the future.

Co-authorship network of co-authors of Xuefei Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefei Bao. A scholar is included among the top collaborators of Xuefei Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefei Bao. Xuefei Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Lulu, Xuefei Bao, Di Fan, et al.. (2025). mTORC1 Selective Nano‐Inhibitor by Disrupting the Lysosomal Arginine‐SLC38A9‐ mTORC1‐CDKs Axis for Precision Bladder Cancer Therapy. Advanced Materials. 37(39). e2504798–e2504798.

Zhong, Ming, Xiaoyuan Wang, Yongshan Zhao, et al.. (2025). Activation of epigenetic reprogramming via crotonylation overcomes resistance to EGFR-TKI therapy in lung cancer. Proceedings of the National Academy of Sciences. 122(40). e2509255122–e2509255122. 1 indexed citations

Wang, Zhe, et al.. (2025). Structural insights into GluN2B-containing NMDA receptor antagonists: a computational approach. New Journal of Chemistry. 49(6). 2319–2334. 1 indexed citations

Song, Chuqiao, et al.. (2024). An alcohol thioetherification method utilizing a domino dual catalysis strategy. Tetrahedron Letters. 155. 155433–155433. 1 indexed citations

Liu, Zhi‐Qiang, et al.. (2024). The synthesis and bioactivities of ROCK2 inhibitors with 1,2-dithiolan-3-yl motif. RSC Medicinal Chemistry. 15(10). 3576–3596. 1 indexed citations

Li, Yao, Junzhou Li, Chun Cai, et al.. (2024). Diversified applications and synthesis of hydroxamic acids. Australian Journal of Chemistry. 77(12).

Wu, Zhixuan, et al.. (2023). A base-free hydroxylaminolysis protocol promoted by ZnO in deep eutectic solvents. Green Chemistry. 25(6). 2446–2452. 4 indexed citations

Zhang, Maoying, et al.. (2023). Design, synthesis and evaluation of l-quebrachitol derivatives against α-glycosidase. New Journal of Chemistry. 47(28). 13387–13396. 1 indexed citations

Chen, Guoliang, et al.. (2023). Henry reaction catalyzed by recyclable polyamine. Tetrahedron Letters. 124. 154557–154557. 1 indexed citations

10.

Wang, Yuning, et al.. (2023). DNA Methyltransferase 3A: A Significant Target for the Discovery of Inhibitorsas Potent Anticancer Drugs. Mini-Reviews in Medicinal Chemistry. 24(5). 507–520. 4 indexed citations

11.

Liu, Ying, et al.. (2022). A recyclable ciprofloxacin polymer ligand for copper-catalyzed coupling of (hetero)aryl halide aminations. New Journal of Chemistry. 46(40). 19100–19103. 2 indexed citations

12.

Bao, Xuefei, et al.. (2022). Recent advances in catalysts for the Henry reaction. Australian Journal of Chemistry. 75(10). 806–819. 5 indexed citations

13.

Zhang, Yong-Sheng, et al.. (2022). Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective. European Journal of Medicinal Chemistry. 235. 114291–114291. 200 indexed citations breakdown →

14.

Bao, Xuefei, et al.. (2021). SET Protein in Cancer: A Potential Therapeutic Target. Mini-Reviews in Medicinal Chemistry. 21(16). 2290–2299. 3 indexed citations

15.

Morisseau, Christophe, Bruce D. Hammock, Xuefei Bao, et al.. (2021). Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis. European Journal of Medicinal Chemistry. 223. 113678–113678. 15 indexed citations

16.

He, Xiaoyan, et al.. (2020). Synthesis of 4-((1H-benzo[d]imidazol-2-yl)oxy)-3-methylpicolinic acid, a key related substance of Rabeprazole sodium. Tetrahedron Letters. 61(30). 152105–152105. 1 indexed citations

17.

Bao, Xuefei, Yuhong Sun, Jiayu Zhang, et al.. (2019). Design, synthesis and evaluation of N-hydroxypropenamides based on adamantane to overcome resistance in NSCLC. Bioorganic Chemistry. 86. 696–704. 6 indexed citations

18.

Li, Hui, et al.. (2019). The synthesis of precursor of FP- (+) DTBZ. Synthetic Communications. 49(22). 3218–3225. 1 indexed citations

19.

Bao, Xuefei, et al.. (2016). The Development of an Effective Synthetic Route of Belinostat. Organic Process Research & Development. 20(8). 1482–1488. 7 indexed citations

20.

Wang, Lihui, Xiaorui Jiang, Jingyu Yang, et al.. (2016). SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis. European Journal of Pharmacology. 791. 560–568. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact